Chemical and biological properties of the world's most expensive spice: Saffron
暂无分享,去创建一个
[1] H. Hosseinzadeh,et al. STUDY OF ANTIDEPRESSANT EFFECT OF AQUEOUS AND ETHANOLIC EXTRACT OF CROCUS SATIVUS IN MICE , 2001 .
[2] H. Hosseinzadeh,et al. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice , 2009, Phytotherapy research : PTR.
[3] M. Recio,et al. An Update Review of Saffron and its Active Constituents , 1996 .
[4] S. Akhondzadeh,et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[5] K. Abe,et al. Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.
[6] Sushanta K Banerjee,et al. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model , 2009, Molecular Cancer Therapeutics.
[7] H. Hosseinzadeh,et al. ANTIDEPRESSANT EFFECT OF CROCUS SATIVUS L. STIGMA EXTRACTS AND THEIR CONSTITUENTS, CROCIN AND SAFRANAL, IN MICE , 2004 .
[8] A. Hensel,et al. Saffron in phytotherapy: Pharmacology and clinical uses , 2007, Wiener Medizinische Wochenschrift.
[9] Y. Shoyama,et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates. , 2000, Anticancer research.
[10] G. Alonso,et al. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. , 1996, Cancer letters.
[11] L. Sheng,et al. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. , 2005, Biochemical pharmacology.
[12] K. Mozaffari,et al. Effects of saffron and its active constituents, crocin and safranal, on prevention of indomethacin induced gastric ulcers in diabetic and nondiabetic rats. , 2009 .
[13] H. Redkey,et al. A new approach. , 1967, Rehabilitation record.
[14] Xiang-chun Shen,et al. Crocetin Prevents Dexamethasone-Induced Insulin Resistance in Rats , 2005, Planta medica.
[15] R. D. Crecchio. The saffron crocus. , 1960 .
[16] Gonzalo L. Alonso,et al. COMPOSITION OF CROCINS AND PICROCROCIN FROM SPANISH SAFFRON (CROCUS SATIVUS L.) , 2001 .
[17] T. Hill. The Contemporary Encyclopedia of Herbs & Spices: Seasonings for the Global Kitchen , 2004 .
[18] G. Eisenbrand,et al. Crocus sativus L. , 1992 .
[19] P. Tarantilis,et al. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[20] H. Tajmir-Riahi,et al. Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties. , 2007, Journal of agricultural and food chemistry.
[21] C. Ito,et al. Pharmacological properties of N-095, a drug containing red ginseng, polygala root, saffron, antelope horn and aloe wood. , 2005, The American journal of Chinese medicine.
[22] Na Wen,et al. Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. , 2007, European journal of pharmacology.
[23] K. Abe,et al. Pharmacological activities of crocin in saffron , 2007, Journal of Natural Medicines.
[24] H. Pfander,et al. Isolation and Structure Elucidation of Carotenoid−Glycosyl Esters in Gardenia Fruits (Gardenia jasminoides Ellis) and Saffron (Crocus sativus Linne) , 1996 .
[25] Fikart I. Abdullaev. Cancer Chemopreventive and Tumoricidal Properties of Saffron (Crocus sativus L.) , 2002, Experimental biology and medicine.
[26] E. Breitmaier. Isolation and Structure Elucidation , 2006 .
[27] Y. S. Lewis,et al. Saffron (Crocus Sativus Linn.) — Cultivation, processing, chemistry and standardization , 1984 .
[28] K. Panikkar,et al. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. , 1991, Nutrition and cancer.
[29] J. Iborra,et al. A non-destructive method to determine the safranal content of saffron (Crocus sativus L.) by supercritical carbon dioxide extraction combined with high-performance liquid chromatography and gas chromatography. , 2000, Journal of biochemical and biophysical methods.
[30] S. Mousavi,et al. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[31] C. Morin. The nature of insomnia and the need to refine our diagnostic criteria. , 2000, Psychosomatic medicine.
[32] G. Ao,et al. Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells. , 2009, Journal of agricultural and food chemistry.
[33] S. Akhondzadeh,et al. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[34] H. Hosseinzadeh,et al. ANTIDEPRESSANT EFFECTS OF CROCUS SATIVUS STIGMA EXTRACTS AND ITS CONSTITUENTS, CROCIN AND SAFRANAL, IN MICE , 2004 .
[35] S. Hagh-Nazari,et al. SAFFRON AND VARIOUS FRAUD MANNERS IN ITS PRODUCTION AND TRADES , 2007 .
[36] S. Taylor,et al. The role of natural color additives in food allergy. , 2001, Advances in food and nutrition research.
[37] L. Sheng,et al. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. , 2006, European journal of pharmacology.
[38] H. Riese,et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. , 1999, Nutrition and cancer.
[39] S. Mousavi,et al. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[40] R. Jagadeeswaran,et al. In vitro studies on the selective cytotoxic effect of crocetin and quercetin. , 2000, Fitoterapia.
[41] S C Nair,et al. Saffron chemoprevention in biology and medicine: a review. , 1995, Cancer biotherapy.
[42] Na Wen,et al. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. , 2005, Life sciences.
[43] S. Akhondzadeh,et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] , 2004, BMC complementary and alternative medicine.
[44] M. Manfait,et al. Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detection. , 1994, Journal of chromatography. A.
[45] M Carmona,et al. A New Approach to Saffron Aroma , 2007, Critical reviews in food science and nutrition.
[46] B. Ranjbar,et al. Interaction of saffron carotenoids as anticancer compounds with ctDNA, Oligo (dG.dC)15, and Oligo (dA.dT)15. , 2007, DNA and cell biology.
[47] S. Akhondzadeh,et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial , 2008, BJOG : an international journal of obstetrics and gynaecology.
[48] N. Karamanos,et al. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. , 2007, Anticancer research.
[49] F. Nabavizadeh,et al. Saffron (Crocus sativus) increases gastric acid and pepsin secretions in rats: Role of nitric oxide (NO) , 2009 .
[50] N. Davies,et al. Effect of drying temperature and air flow on the production and retention of secondary metabolites in saffron. , 2005, Journal of agricultural and food chemistry.
[51] R. Liu,et al. Potential synergy of phytochemicals in cancer prevention: mechanism of action. , 2004, The Journal of nutrition.
[52] N. Bisset. Herbal drugs and phytopharmaceuticals , 1994 .
[53] Growing saffron - the world’s most expensive spice , 2003 .
[54] S. Akhondzadeh,et al. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.
[55] Gonzalo L. Alonso,et al. Worldwide market screening of saffron volatile composition , 2009 .
[56] M. Polissiou,et al. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. , 2006, Journal of agricultural and food chemistry.
[57] S. Akhondzadeh,et al. Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial , 2004, Phytotherapy research : PTR.
[58] K. Panikkar,et al. Antitumour activity of saffron (Crocus sativus). , 1991, Cancer letters.
[59] Jen-kun Lin,et al. Inhibition of protein kinase C and proto‐oncogene expression by crocetin in NIH/3T3 cells , 1996, Molecular carcinogenesis.
[60] A. Assimopoulou,et al. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents , 2005, Phytotherapy research : PTR.
[61] Guanglin Xu,et al. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. , 2007, The Journal of nutritional biochemistry.
[62] H. Hosseinzadeh,et al. Kaempferol from Saffron Petals , 2003 .
[63] P. Variyar,et al. Chemical investigation of gamma-irradiated saffron (Crocus sativus L.). , 2001, Journal of agricultural and food chemistry.
[64] Moschos G. Polissiou,et al. Isolation and Identification of the Aroma Components from Saffron (Crocus sativus) , 1997 .